Healthy adults below the age of 30 years in the United Kingdom (UK) will be given an alternative to the AstraZeneca covid-19 vaccine after evidence showed that it is linked to one of the most rear form of blood clots.
Even though regulators believe that there is no concrete evidence on the blood clot link, 19 out of the 79 people that recorded the blood clots already succumbed to the same. The Medicines and Healthcare products Regulatory Agency (MHRA) also said that 20 million doses had so far been administered in the country.
Further, officials have reiterated that the many benefits of receiving the AstraZeneca covid-19 vaccine outweighs the risks and side effects experienced by the vast majority, insisting that the vaccine is “safe, effective, and has saved thousands of lives”. As a result, they urged the countries around the world to continue giving their citizens the jab without worrying much.
In the meantime, Netherlands recently banned the use of the AstraZeneca Oxford vaccine for those aged 60 years and below, arguing that they were at high risk of experiencing blood clots.
Through a statement, the Dutch government confirmed that there were five reports of thrombosis and abnormally low platelets that assist in blood clot for women aged between 25 to 65 years of age. This comes amidst confirmation by the government that more than 400,000 AstraZeneca injections have been given to the citizens in Netherlands.
“The crucial question is whether it concerns complaints after vaccination or due to vaccination … We must err on the side of caution, which is why it is wise to press the pause button now as a precaution.” Said the outgoing health minister Hugo de Jonge.